Foghorn Therapeutics, Inc.

Contributing Author

Recent Articles by Foghorn Therapeutics, Inc.

Oct-30	Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs FHTX GlobeNewswire
Oct-16	Foghorn Therapeutics Announces Significant Progress for Selective ARID1B Degrader at the 8th Annual TPD and Induced Proximity Summit FHTX GlobeNewswire
Aug-27	Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences FHTX GlobeNewswire
Aug-05	Foghorn Therapeutics Provides Second Quarter 2025 Financial and Corporate Update FHTX GlobeNewswire
May-22	Foghorn Therapeutics to Participate in Four Upcoming Investor Conferences FHTX GlobeNewswire
May-14	Foghorn Therapeutics Provides First Quarter 2025 Financial and Corporate Update FHTX GlobeNewswire
May-05	Foghorn Therapeutics to Participate in the Citizens Life Sciences Conference FHTX GlobeNewswire